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Background
Atopic dermatitis (AD) is a chronic, recurrent inflamma-
tory skin disease. Due to deficient skin barrier function,
patients with AD are exposed to higher risk of contact
sensitization and allergic contact dermatitis. Basic therapy
of AD should consist of optimal skin care pointed at the
skin barrier defect with regular use of emollients. Unfortu-
nately, products from this group can potentially comprise
compounds listed in European Baseline Series (EBS) used
in the patch test allergens. The aim of this study was to
determine the prevalence of allergens listed in European
Baseline Series included in preparations available in polish
online drugstores.
Method
About 40 online drugstores were searched by two inde-
pendent researchers. We included preparations described
by the manufacturers as “emollients” or “products able for
treatment of atopic dermatitis” and subsequently assessed
for their presence of chemical compounds included to list
of the EBS(28 most common allergens). The analysis also
included the cost of each product (all collected on the
same day, 28 Jan 2014).
Results
196 preparations met our inclusion criteria. 17 of them
(8,7%) weren’t examined because of the lack of informa-
tion about ingredients based on INCI (International
Nomenclature of Cosmetics Ingredients). The analysis of
the data revealed that 60 (58,3%) emollient products
contained Parabens, 25 (24,3%)- Wool alcohols, 17
(16,5%)- Fragrance mix I, 7(6,8%)- 5-chloro-2-methyl-4-
isothiazolin-3-one (Cl+Me-isothiazolinone), 10(9,7%)- For-
maldehyde, 9 (8,7%)- Fragrance mix II. 49 out of them
(47,6%) contained fragrances not included in EBS. Among
179 preparations, only 71(39,7%) met the criteria of ingre-
dients deprived of allergens listed in EBS. Our study
showed that 36 (50,7%) out of them were more expensive
than 50z³ per 200 ml, whereas 35 (49,3%) of them were
cheaper.
Conclusion
Current analysis of composition of emollient preparations
demonstrated that majority of them contained allergens
listed in EBS. There was no correlation between high
price of preparation and allergen deprived composition.
In view of increasing incidence of atopic dermatitis in
children, a wide range of emollient preparations is
observed. This is a matter of public concern not to allow
products used in AD to do harm to children. This study
underscores that additional chemical compounds in
emollient preparations are avoidable risk factor for the
development of contact dermatitis in children.
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